c myc (Danaher Inc)
Danaher Inc is a verified supplier 
Danaher Inc manufactures this product 
99
Structured Review
Danaher Inc
c myc
C Myc, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1379 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ab78852/Recombinant+Anti-EGFR+antibody/pm32061924-83-76-97
Average 99 stars, based on 1379 article reviews
C Myc, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1379 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ab78852/Recombinant+Anti-EGFR+antibody/pm32061924-83-76-97
Average 99 stars, based on 1379 article reviews
c myc - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer Article Snippet: The following Staining:Article Title: MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer Article Snippet: BlueEye Prestained Protein Marker (#PS-104; Jena Bioscience) and 20 μg of protein were separated on NuPAGE 4-12% Bis-Tris Mini Protein Gels (#NP0323; Thermo Fisher Scientific) using NuPAGE MOPS SDS Running Buffer (#NP0001; Thermo Fisher Scientific), and transferred overnight at 4°C onto Nitrocellulose Membranes (#88018; Thermo Fisher Scientific) in transfer buffer (25 mM Tris, 2 M Glycine, 20% methanol in demineralized water). .. Membranes were stained with Ponceau S (#ab270042; Abcam) and imaged with Fusion FX (Vilber), blocked in 5% bovine serum albumin (BSA; #A8022; Sigma-Aldrich) in PBS-T (0.05% Tween-20), and incubated in 5% BSA in PBS-T overnight at 4°C with the following primary antibodies: β-actin (1:10,000, #A5441; Sigma-Aldrich), Article Title: MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer Article Snippet: .. Tissues were formalin-fixed and paraffin-embedded (FFPE) by routine procedures and sectioned for H&E histochemical staining and IHC stainings, which were performed as previously described ( ) using primary antibodies against E-cadherin (1:200, #3195; Cell Signaling Technology), Incubation:Article Title: MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer Article Snippet: BlueEye Prestained Protein Marker (#PS-104; Jena Bioscience) and 20 μg of protein were separated on NuPAGE 4-12% Bis-Tris Mini Protein Gels (#NP0323; Thermo Fisher Scientific) using NuPAGE MOPS SDS Running Buffer (#NP0001; Thermo Fisher Scientific), and transferred overnight at 4°C onto Nitrocellulose Membranes (#88018; Thermo Fisher Scientific) in transfer buffer (25 mM Tris, 2 M Glycine, 20% methanol in demineralized water). .. Membranes were stained with Ponceau S (#ab270042; Abcam) and imaged with Fusion FX (Vilber), blocked in 5% bovine serum albumin (BSA; #A8022; Sigma-Aldrich) in PBS-T (0.05% Tween-20), and incubated in 5% BSA in PBS-T overnight at 4°C with the following primary antibodies: β-actin (1:10,000, #A5441; Sigma-Aldrich), Article Title: USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity Article Snippet: .. Membranes were blocked for 1 h in 5% milk followed by overnight incubation with primary antibodies directed against USP13 (Santa Cruz, Cat# sc-514416), NKX2-1 (Abcam, Cat#ab76013), SOX2 (CST, cat#14962), Formalin-fixed Paraffin-Embedded:Article Title: MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer Article Snippet: .. Tissues were formalin-fixed and paraffin-embedded (FFPE) by routine procedures and sectioned for H&E histochemical staining and IHC stainings, which were performed as previously described ( ) using primary antibodies against E-cadherin (1:200, #3195; Cell Signaling Technology), Immunohistochemistry:Article Title: MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer Article Snippet: .. Tissues were formalin-fixed and paraffin-embedded (FFPE) by routine procedures and sectioned for H&E histochemical staining and IHC stainings, which were performed as previously described ( ) using primary antibodies against E-cadherin (1:200, #3195; Cell Signaling Technology), Immunopeptidomics:Article Title: MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer Article Snippet: .. Tissues were formalin-fixed and paraffin-embedded (FFPE) by routine procedures and sectioned for H&E histochemical staining and IHC stainings, which were performed as previously described ( ) using primary antibodies against E-cadherin (1:200, #3195; Cell Signaling Technology), FLAG-tag:Article Title: USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity Article Snippet: .. Membranes were blocked for 1 h in 5% milk followed by overnight incubation with primary antibodies directed against USP13 (Santa Cruz, Cat# sc-514416), NKX2-1 (Abcam, Cat#ab76013), SOX2 (CST, cat#14962), |
